Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04932291 |
|
Recruitment Status :
Completed
First Posted : June 21, 2021
Last Update Posted : November 28, 2023
|
Sponsor:
Oryzon Genomics S.A.
Information provided by (Responsible Party):
Oryzon Genomics S.A.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 30, 2023 |
| Actual Study Completion Date : | November 13, 2023 |